glp-1 obesity drug news today september 2025 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Care GLP-1 Receptor Agonists – From
Description
As TruShield Certified founder Lori Bestervelt, Ph.D
Ken Fujioka, Department of Nutrition and Metabolic Research, Scripps Clinic, La Jolla, California, and a SCALE clinical trial investigator
Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease
GLP-1s are becoming a mainstay for weight loss and diabetes treatment, and the demand for this type of drug is high
Bagsvaerd, Denmark: Novo Nordisk
Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas
